Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:RXRX   3:59:51 PM EDT
5.44
-0.36 (-6.21%)
Earnings Announcements

Recursion Pharmaceuticals Inc Posts Qtrly Loss Per Share Of 38 Cents

Published: 03/23/2022 12:19 GMT
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A (RXRX) - Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results.
Recursion Pharmaceuticals Inc - Total Revenue, Consisting Primarily of Revenue From Collaborative Agreements, Was $2.5 Million for Q4 of 2021.
Recursion Pharmaceuticals Inc - Qtrly Loss per Share $0.38.
Recursion Pharmaceuticals Inc - Cash, Cash Equivalents, and Investments Were $516.6 Million As of December 31, 2021.
Revenue is expected to be $5.33 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $5.47 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.